Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Report by
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Transit station

Updated: April 7, 2021 12:00 PM

Covid-19 OSHA Complaint, Greyhound Lines Inc, 550 NW 6th Ave, PORTLAND, OR, 97209, USA

Greyhound Lines Inc, 550 NW 6th Ave, PORTLAND, OR, 97209, USA

April 7, 2021 12:00 PM

“Serious

Alleged Hazards: 1,
Source: Osha.gov | Receipt Date: 2021-01-04 See Less
Reported By Iwaspoisoned.com User

An Employee test positive for Covid-19, Steamship Authority Ferry Docks, Woods Hole, Falmouth, MA 02543, United States

Steamship Authority Ferry Docks, Woods Hole, Falmouth, MA 02543, United States

April 6, 2021 12:00 PM

“An employee at Steamship Authority Ferry Docks located on Woods Hole in Falmouth recently tested positive for Covid-19.

Source: mvtimes.com See Less
Reported By Iwaspoisoned.com User

Covid-19 OSHA Complaint, ITP, 300 Ellsworth Ave, GRAND RAPIDS, MI, 49503, USA

ITP, 300 Ellsworth Ave, GRAND RAPIDS, MI, 49503, USA

March 24, 2021 12:00 PM

“1. Per the new Michigan Department of Health and Human Services Order Under MCL 333.2253 each person must wear a mask when in a indoor shared space. There are no exceptions made for public transportation, nor is public transportation listed in a special category in the Order. The order says a busine... See Moress MAY accept individual's word on a mask exemption. It doesn't say they MUST. Several organizations consider a maskless individual to be a possible COVID 19 carrier and do not allow them entry into their business. The Rapid allows any passenger to state they have a medical condition and ride without a mask. Transporting a maskless passenger puts the bus driver at risk of contracting COVID 19. 2. On October 21st management sent out a message to drivers via the Avail message system that " if a passenger tells you they have a medical condition AND they cant wear a mask you must let them ride. This is the one exception to the mandatory mask policy. Questions? Ask a supervisor". This company policy violates the MI DHHS order which only allows a person to not wear a mask when they cannot medically tolerate it. Not the more liberal company interpretation of " when they have a medical condition". Not all medical conditions (for example, bone spurs) would allow an individual to state that a mask is not able to be medically tolerated. 3. The Rapid states the ADA as being the law they use for guidance regarding requiring individuals to wear a mask. They state that drivers must wear some type of face covering and require they provide a note from a doctor to be excused from wearing a mask. Those drivers who can't wear a mask must at least wear a face shield. The Rapid allows any passenger to simply state they have medical condition and wear no face covering whatsoever (mask or face shield). Drivers are required to transport a maskless passenger for a bus trip that can last up to an hour and a half putting both driver and other passengers at risk. It has recently been discovered that COVID 19 can spread via aerosolized droplets that can stay in the air for up to 3 hours and can travel much further than 6 feet. This increases the chance that a maskless passenger could infect both the driver or other passengers. 4. While the Rapid states the ADA is the reason they allow anyone with a medical condition to ride without a mask, "The ADA does not provide a blanket exemption to people with disabilities from complying with legitimate safety requirements necessary for safe operations," the Department of Justice Department, which helps enforce the ADA, said in a June 30 press release. The ADA also has a clause that deals with a direct threat as a result of accommodating a disability. A direct threat under the ADA is any substantial risk to the health and safety a disabled person poses to others, which cannot be countered with reasonable accommodations. With a high COVID 19 positivity rate, we should assume anyone could be a carrier. Accommodating someone to ride without a face covering whatsoever creates a direct threat as the individual could have COVID 19 or be a carrier. 5. While the Rapid has a paratransit unit ( Go Bus) to accommodate those with disabilities (that restrict them from riding the standard line haul buses), they refuse to use this service for its purpose in terms of those with mask Intolerances. For example, if someone has a disability or medical condition that makes a mask medically intolerant that individual could ride the Go Bus which in turn could be more easily protected (via barriers between passenger and driver) and more easily cleaned (due to their small size). 6. The MI DHHS order has restrictions on gatherings (as defined as 2 or more people from a different household in a shared space). space). The order restricts individuals in a shared space to 10 people in an indoor space or 20% of the number of seats. No exceptions are made for public transportation. The Rapid has ignored this order and often has buses crammed full of


Source: Osha.gov | Receipt Date: 2020-10-26
See Less
Reported By Iwaspoisoned.com User
Vaccine Side Effects Special summary

Covid-19 OSHA Complaint, WA ST TRANSPORTATION DEPT OF, 2100 Ferry Terminal Rd., ANACORTES, WA, 98221, USA

WA ST TRANSPORTATION DEPT OF, 2100 Ferry Terminal Rd., ANACORTES, WA, 98221, USA

March 24, 2021 12:00 PM

“At the Anacortes Ferry Terminal, employees that have been knowingly exposed to Covid-19 are continuing to work, exposing co-workers to the virus. Multiple crews have been exposed to Covid-19, Management is telling crews to return to work no matter what. Anacortes Terminal 2100 Ferry Terminal Rd., An... See Moreacortes, WA 98221


Source: Osha.gov | Receipt Date: 2021-01-29
See Less
Reported By Iwaspoisoned.com User

Covid-19 OSHA Complaint, Amtrak, 810 N. Alameda St., LOS ANGELES, CA, 90012, USA

Amtrak, 810 N. Alameda St., LOS ANGELES, CA, 90012, USA

March 17, 2021 12:00 PM

“T8CCR 3203(a) - Management is sending trains out short staffed making it impossible to sanitize and disinfect trains properly during COVID-19.


Source: Osha.gov | Receipt Date: 2020-07-15 See Less
Reported By Iwaspoisoned.com User

An Employee test positive for Covid-19, Swartz Bay Terminal, 11300 Patricia Bay Hwy, Sidney, BC V8L 3S8, Canada

Swartz Bay Terminal, 11300 Patricia Bay Hwy, Sidney, BC V8L 3S8, Canada

February 28, 2021 12:00 PM

“An employee at Swartz Bay Terminal located on Patricia Bay Hwy in Sidney recently tested positive for Covid-19.

Source: twitter.com See Less
Reported By Iwaspoisoned.com User

An Employee test positive for Covid-19, Swartz Bay Terminal, 11300 Patricia Bay Hwy, Sidney, BC V8L 3S8, Canada

Swartz Bay Terminal, 11300 Patricia Bay Hwy, Sidney, BC V8L 3S8, Canada

February 25, 2021 12:00 PM

“An employee at Swartz Bay Terminal located on Patricia Bay Hwy in Sidney recently tested positive for Covid-19.

Source: twitter.com See Less
Reported By Iwaspoisoned.com User

Covid-19 OSHA Complaint, Greyhound, 420 Richards Blvd., SACRAMENTO, CA, 95811, USA

Greyhound, 420 Richards Blvd., SACRAMENTO, CA, 95811, USA

February 17, 2021 12:00 PM

“3205(c)(2): Buses from Oregon to Sacramento: Passengers and bus drivers do not wear face coverings.

Alleged Hazards: 1, Employees Exposed: 1
Source: Osha.gov | Receipt Date: 2021-01-05 See Less
Reported By Iwaspoisoned.com User

Covid-19 OSHA Complaint, First Transit, Inc., 60 East Arby Avenue, LAS VEGAS, NV, 89119, USA

First Transit, Inc., 60 East Arby Avenue, LAS VEGAS, NV, 89119, USA

February 17, 2021 12:00 PM

“1. The employer is not complying with the Governor's COVID-19 mandate in regard to disinfecting the buses in between customer rides. The buses are also not being disinfected in between shifts. The staff assigned to assist drivers with sanitization are only available from 6 AM to 2 PM and are not ava... See Moreilable on all 3 shifts. The passenger high touch surfaces such as the poles, seats, and luggage racks are not being disinfected to prevent the spread of the COVID-19 virus. Hazard Location 50 buses, most buses are in service unless they have mechanical issues. 95% of buses are normally in service, daily. 12/3/2020 GC

Alleged Hazards: 1, Employees Exposed: 75
Source: Osha.gov | Receipt Date: 2020-12-03
See Less
Reported By Iwaspoisoned.com User

21 Employees test positive for Covid-19, Memphis Area Transit Authority American Way Transit Center, Memphis, TN, USA

Memphis Area Transit Authority American Way Transit Center, Memphis, TN, USA

February 11, 2021 12:00 PM

“21 employees at Memphis Area Transit Authority American Way Transit Center recently tested positive for Covid-19.

Source: wmcactionnews5.com See Less
Reported By Iwaspoisoned.com User

Recent Interesting Reports

April 2, 2021 8:00 PM

“Company name: A-S Medication Solutions, LLM
Brand name: A-S Medication Solutions, LLM
Product recalled: Acetaminophen Extra Strength 500 mg Tablets, 100 ct. bottles contained in Health Essentials Kits distributed by Humana
Reason of the recall: Products contain an incomplete prescription drug lab... See Moreel
FDA Recall date: April 02, 2021
Recall details: Libertyville, IL, A-S Medication Solutions, LLM (ASM) is voluntarily recalling 198,350 bottles of Acetaminophen Extra Strength 500 mg Tablets, 100 ct. bottles (NDC# 50090-5350-0) contained in Health Essentials Kits distributed by Humana to its members. See the photo below. This recall is being conducted to the consumer level. These over-the-counter (OTC) analgesic products contain an incomplete prescription drug label rather than the required OTC Drug Facts label.

Risk Statement: Use of acetaminophen could be potentially harmful if safety warnings contained on the OTC label are not observed including: liver damage if consumers exceed the recommended dose, combine use with excessive consumption of alcohol, or are allergic to the active ingredient. To date, the Company has not received any reports of adverse events related to this recall.

The product is used as a pain and fever reliever. The 100-count bottles labeled with NDC 50090-5350-0 are packaged in white plastic bottles contained in a clear plastic bag with other seasonal products labeled as a Health Essentials Kit. Distribution likely occurred between 1/14/21 and 3/15/21 nationwide in the USA. Expiration dates are either 7/31/22 or 8/31/22. The affected bottles that should be returned contain a short Rx drug label that lacks the full OTC Drug Facts chart.

ASM is also notifying its distributors and customers by mail and is arranging for return of all recalled products. Consumers and distributors that have this product which is being recalled should stop using it and return it in preaddressed return mailers that will be provided by ASM or the distributors.

Consumers with questions regarding this recall can contact ASM by telephone at 847.680.3515 x 236, from 9-5 p.m. CST, or e-mail at anel.figueroa@a-smeds.com. Consumers should contact their physician or healthcare provider if they experience any problems that may be related to taking or using this or any drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

- Complete and submit the report Online.
- Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

NDC # 50090-5350-0 Lot #s 323206, 323207, 323208, 323209, 323210, 323211, 323212, 323213, 323214, 323215, 323216, 323218, 323219, 323220, 323222, 323223, 323224, 323238, 335353, 335354, 335355, 335356, 335358, 335359, 335360, 335361, 335362, 335363, 335364, 335365, 335366, 33536, 335368, 335369, 335370, 335371, 335372, 335373, 335374, 335375, 335376, 335377, 335395, and 352116.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

April 9, 2021 6:05 PM

“Company name: NS NY Distributor Inc
Brand name: NS NY Distributor Inc
Product recalled: Premium Orgazen 7000 and Ginseng Power 5000 capsules
Reason of the recall: Undeclared Sildenafil and/or Tadalafil
FDA Recall date: April 09, 2021
Recall details: Company Announcement NS NY Distributor Inc is... See Morevoluntarily recalling all lots within expiry of Premium Orgazen 7000 and Ginseng Power 5000 capsules to the consumer level. FDA  analyses has found the products to contain undeclared sildenafil and/or tadalafil. Sildenafil and tadalafil are known as phosphodiesterase (PDE-5) inhibitors found in FDA approved products for the treatment of male erectile dysfunction. The presence of sildenafil and/or tadalafil in Premium OrgaZen 7000 and Ginseng Power 5000 makes them unapproved new drugs for which the safety and efficacy have not been established and therefore subject to recall. Consumers with underlying medical issues who take Premium OrgaZen 7000 capsules and Ginseng Power 5000 with undeclared sildenafil and/or tadalafil may experience serious health risks. For example, PDE-5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels that may be life-threatening. Consumers with diabetes, high blood pressure, or heart disease often take nitrates. To date, NS NY Distributor Inc has not received any reports of adverse events related to this recall. These tainted products are marketed as a dietary supplements for male sexual enhancement and are packaged in a single capsule blister foil sheet and sold in lots of 3 capsules, 5 capsules and 10 capsules. The affected lot numbers of Premium OrgaZen 7000, UPC 0 40232 18144 3, and Ginseng Power 5000, UPC 0 40232 18144 3 include all lots. Premium OrgaZen 7000 and Ginseng Power 5000 were distributed nationwide in the USA via the internet by seller account Beauty.Kor. and fulfilled by amazon at www.amazon.com. NS NY Distributor Inc is notifying customers who purchased through Amazon seller account Beauty.Kor by this press announcement. Consumers that have Premium OrgaZen 7000 and Ginseng Power 5000 which are being recalled should stop using and destroy them. Consumers with questions regarding this recall can contact NS NY Distributors Inc by email at NSNYdistributors@gmail.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online by regular mail or by fax. Complete and submit the report Online
Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Check the full recall details on fda.gov
Source: FDA
See Less
Reported By SafelyHQ.com User

March 30, 2021 10:00 AM

“Company name: Bit & Bet LLC
Brand name: Thumbs Up 7
Product recalled: Blue 69K Dietary Supplement for male sexual enhancement
Reason of the recall: Undeclared Sildenafil and Tadalafil
FDA Recall date: March 30, 2021
Recall details: Bit & Bet LLC is voluntarily recalling all lots of Thumbs Up 7... See MoreBlue 69K capsules to consumer level. FDA analysis has found the product to contain undeclared sildenafil and tadalafil. Sildenafil and tadalafil are ingredients known as phosphodiesterase (PDE-5) inhibitors found in FDA approved products for the treatment of male erectile dysfunction.

The presence of sildenafil and tadalafil in Thumbs Up 7 Blue 69K capsules make them unapproved new drugs for which the safety and efficacy have not been established and, therefore subject to recall. Consumers with underlying medical issues who take Thumbs Up 7 Blue 69K capsules with undeclared sildenafil and tadalafil may experience serious health risks. For example, PDE-5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels that may be life-threatening. Consumers with diabetes, high blood pressure, or heart disease often take nitrates.

To date, Bit & Bet has not received any reports of adverse events related to this recall. To date, Bit & Bet has not received any reports of adverse events related to this recall This tainted product is marketed as a dietary supplement for male sexual enhancement and is packaged in blister foil sheets in a box labeled with UPC 6 17135 89467 3. Each box contains 10 capsules. The affected lot numbers of Thumbs Up 7 Blue 69K includes all lots. Thumbs Up 7 Blue 69K was distributed via internet and fulfilled by amazon at www.amazon.com nationwide in the USA.

On December 17, 2020, FDA issued a press release that warned consumers to avoid certain products found on Amazon, e Bay and other retailers due to hidden and potentially dangerous drug ingredients. It also encouraged online marketplaces to ensure these products are not sold on their platforms. Bit & Bet LLC is notifying its customers by this press announcement and via email of this recall. Consumers that have Thumbs up 7 Blue 69K, which is being recalled should stop using and descard them.

Consumers with questions regarding this recall can contact Bit & Bet LLC by phone at (201) 208-2836 Monday to Friday from 9AM to 5PM or e-mail thumbsup7blue@gmail.com. For more information, please visit www.thumbsup7blue.com. Consumers should contact their physicians or healthcare provider if they have experienced any problems that may be related to takin or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User
Vaccine Side Effects Special summary

March 24, 2021 9:25 AM

“My yar old cocker spaniel just had a seizure  after giving him 2 dream bone peanut butter treats! Poor lil guy ate 2 of these shitty made in China peanut butter treats! Next thing I see is him convulsing on the floor uncontrollably! Very sad to have to watch! His half sister has been having them for... See More2 years , but it’s gotta be coming from this treat. Do not ever feed your dogs these. I am devasted to now have 2 dogs that have has seizures due to this. See Less
Reported By SafelyHQ.com User

April 6, 2021 5:00 PM

“Company name: Yolo Studio
Brand name: PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500
Product recalled: Dietary Supplement for male sexual enhancement
Reason of the recall: Undeclared Tadalafil
FDA Recall date: April 06, 2021
Recall details: Company Announcement Cli... See Moreffside Park, NJ, Yolo Studio is voluntarily recalling all lots of PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 to the consumer level. FDA analysis has found the product to contain undeclared tadalafil. Tadalafil is ingredient known as a phosphodiesterase (PDE-5) inhibitor found in FDA approved products for the treatment of male erectile dysfunction. The presence of tadalafil in PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 makes these unapproved new drugs for which the safety and efficacy have not been established and, therefore subject to recall.

Consumers with underlying medical issues who take PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 with undeclared tadalafil may experience serious health risks. For example, PDE- 5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels that may be life-threatening. Consumers with diabetes, high blood pressure, or heart disease often take nitrates. To date, Yolo Studio has not received any reports of adverse events related to this recall. These tainted products are marketed as dietary supplements for male sexual enhancement and are packaged in cardboard blisters containing one pill per card.

The affected lot numbers of PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 include all lots. PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 were distributed via internet and fulfilled by amazon at www.amazon.com nationwide in the USA. On December 17, 2020, FDA issued a press release that warned consumers to avoid certain products found on Amazon, eBay and other retailers due to hidden and potentially dangerous drug ingredients. It also encouraged online marketplaces to ensure these products are not sold on their platforms.

Yolo Studio is notifying its customers by this press announcement and via e-mail of this recall. Consumers that have PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 which are being recalled should stop using and destroy them. Consumers with questions regarding this recall can contact Yolo Studio by phone at (201) 233-3521 Monday through Friday from 9am to 5pm eastern time zone or e-mail yolostudiodamazon@gmail.com.

Consumers should contact their physicians or healthcare provider if they have experienced any problems that may be related to taking or using these drug products. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

- Complete and submit the report Online.
- Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

March 25, 2021 11:00 AM

“Company name: Zydus Pharmaceuticals Inc.
Brand name: Zydus Pharmaceuticals
Product recalled: Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials
Reason of the recall: Due to Crystalization
FDA Recall date: March 25, 2021
Recall details: Pennington, NJ, Zydus Pharmaceuticals (USA) Inc. i... See Mores voluntarily recalling four lots of Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials, to the Hospital/User level after receiving several complaints of crystallization in vials.

Administration of crystalized Acyclovir Sodium Injection, 50 mg/mL has a potential of life-threatening adverse consequences including injection site inflammation of a vein and local reactions, damage and/or obstruction of blood vessels, which could induce clots, particularly in the lungs, the passage of the particulate matter into the bloodstream may lead to clots resulting in stroke, heart attack, decreased liver or kidney function or death of tissues or cells.

To date, Zydus Pharmaceuticals (USA) Inc. has not received any reports of adverse events related to this product recall. Acyclovir Sodium Injection, 50 mg/mL is indicated for the treatment of herpes simplex infections in immunocompromised patients, severe initial clinical episodes of herpes genitalis in immuno-competent patients, herpes simplex encephalitis, neonatal herpes simplex virus infection and varicella-zoster (shingles) infections in immunocompromised patients.

The product is packaged in single-dose glass vials and was distributed nationwide in the USA to Cardinal Health, Amerisourcebergen Drug Corporation and Morris & Dickson Company LLC. The affected Acyclovir Sodium Injection, 50 mg/mL lots include the following lot numbers and expiration dates:

- Acyclovir Sodium Injection, 50 mg/mL, 20 mL. Carton NDC Number: 68382-049-10. Vial NDC Number: 68382-049-01. Lot Number: L000155. Expiry Date: Dec 2021. Pack Size: 10x20 mL, Single-Dose Vial pack.

- Acyclovir Sodium Injection, 50 mg/mL, 20 mL. Carton NDC Number: 68382-049-10. Vial NDC Number: 68382-049-01. Lot Number: L000156. Expiry Date: Jan 2022. Pack Size: 10x20 mL, Single-Dose Vial pack.

- Acyclovir Sodium Injection 50 mg/mL, 10 mL. Carton NDC Number: 68382-048-10. Vial NDC Number: 68382-048-01. Lot Number: L000126. Expiry Date: Dec 2021. Pack Size: 10x10 mL, Single-Dose Vial pack.

- Acyclovir Sodium Injection 50 mg/mL, 10 mL. Carton NDC Number: 68382-048-10. Vial NDC Number: 68382-048-01. Lot Number: L000127. Expiry Date: Dec 2021. Pack Size: 10x10 mL, Single-Dose Vial pack.

Zydus Pharmaceuticals (USA) Inc. has notified its distributors and customers by email and FedEx overnight courier service and is arranging for the return of all recalled Acyclovir Sodium Injection, 50 mg/mL lots. Hospitals that have the product which is being recalled should stop using it immediately and call our recall coordinating center at 1-855-671-5023 [Call: 1-855-671-5023] Monday – Friday (excluding holidays), 9:00 am to 5:00 pm EST.

Consumers with questions regarding this recall can contact Zydus Pharmaceuticals (USA) Inc. by phone: 1-877-993-8779 [Call: 1-877-993-8779] or by email: medicalaffairs@zydususa.com Monday – Friday (excluding holidays), 9:00 am to 5:00 pm EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

March 23, 2021 5:59 PM

“All I received was the chain and straps not the chain saw how can I get my money back? I am 73 and got cheated out of $29.99 plus tax for a chain saw when all I received was a chain and I want my money back See Less
Reported By SafelyHQ.com User

March 24, 2021 4:00 PM

“Company name: Alembic Pharmaceuticals, Inc.
Brand name: Alembic
Product recalled: Telmisartan Tablets, USP, 20 mg
Reason of the recall: Incorrect Product Strength on Label
FDA Recall date: March 24, 2021
Recall details: Bridgewater, NJ, Alembic Pharmaceuticals, Inc is voluntarily recalling on... See Moree lot of Telmisartan Tablets, USP, 20 mg, packaged in 30-count bottles, Lot No. 1905005661 to the consumer level. The product is being recalled due to a market complaint received which stated that one bottle labelled as 30-count Telmisartan Tablets, USP, 20 mg incorrectly contained 30 tablets of Telmisartan Tablets, USP, 40mg.

Risk Statement: Patients who could be on a doubled dose of telmisartan for a prolonged period of time, could experience low blood pressure, worsening of kidney function, or an elevation of potassium which can be life-threatening. To date, Alembic Pharmaceuticals Limited has not received any reports of adverse events related to this recall. The product is used for the treatment of hypertension i.e. to lower blood pressure and is packaged in a bottle of 30 tablets having NDC Number 62332-087-30.

The affected lot of Telmisartan Tablets, USP, 20 mg is the lot number 1905005661 and the lot expires in March 2022. The wrong product can be identified by checking the shape and embossing details on the tablets i.e. Telmisartan Tablets, USP, 20 mg bottles may incorrectly contain oval shaped White to off-white tablets debossed with L203 on one side instead of correct product i.e. round shaped White to off-white tablets debossed with L 202 on one side. Telmisartan Tablets, USP, 20mg, Lot No. 1905005661 was distributed Nationwide in the USA to wholesalers, retailers, and pharmacies.

Alembic Pharmaceuticals Limited is notifying its distributors and retailers through letter and is arranging for return of the recalled lot. Consumers that may have Telmisartan Tablets, USP, 20 mg which is being recalled should not discontinue use until speaking with their pharmacist or healthcare professional for a replacement before returning to place of purchase. Consumers with questions regarding this recall can contact Alembic Pharmaceuticals Inc by phone at +1 908-552-5839 (9:00 am – 5:00 pm, EDT, Monday through Friday) or email address david.cobb@alembicusa.com.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

Modern, Merced County, CA, USA

Symptoms: Other Fatigue
Merced County, CA, USA

March 29, 2021 10:43 PM

“First injection:
No issues with injection and no side effects.
Second injection:
Immediately following injection, blood ran down my arm. They claimed that a vein was punctured, but that the vaccination went in just fine. I questioned them again to make sure. And they insisted it was fine. The f... See Moreirst night following injection, my body was uncomfortable and I was unable to get into a deep sleep. 24hrs after injection, the injection site was surrounded by a large patch of red skin that was hot to the touch. At 28 hours, fatigue and malaise set in. At 48hrs, I felt markedly better, although still fatigued. The injection site was much less inflamed. See Less
Reported By SafelyHQ.com User

I am reporting Pfizer vaccine, Lecompte, LA 71346, USA

Symptoms: Other Headache
Lecompte, LA 71346, USA

March 22, 2021 7:48 PM

“In February I received my 1st dose of Pfizer vaccine and I did get a headache.. yet it was the second dose on March 3 that made me go to the doctor and found that that vaccine has cause me to have high high blood pressure! My numbers doubled and I have not recovered. Now on high blood pressure me... See Moreds. The doctor says I have fluid built up around my heart and palpitations that are driving me to unhappy days.
Letting you know. .
See Less
Reported By SafelyHQ.com User